LAMEDITECH Co., Ltd. (KOSDAQ:462510)
South Korea · Delayed Price · Currency is KRW 5,990.00
+900.00 (17.68%)
Feb 24, 2026, 3:30 PM KST
LAMEDITECH Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Other Revenue | -0 | - | - | -0 | 0 | - |
| 7,380 | 6,577 | 2,918 | 2,056 | 1,029 | 204.14 | |
Revenue Growth (YoY) | 33.74% | 125.37% | 41.95% | 99.85% | 403.91% | -68.07% |
Cost of Revenue | 4,376 | 4,220 | 2,019 | 1,771 | 661.81 | 380.83 |
Gross Profit | 3,005 | 2,357 | 899.43 | 284.81 | 366.86 | -176.7 |
Selling, General & Admin | 12,323 | 10,306 | 3,510 | 2,242 | 1,531 | 1,167 |
Research & Development | 1,542 | 1,466 | 765.3 | 1,260 | 680.28 | 544.34 |
Amortization of Goodwill & Intangibles | 21.17 | 16.14 | 8.01 | 10.41 | 9.85 | 7.72 |
Other Operating Expenses | - | - | - | - | 6.58 | 5.82 |
Operating Expenses | 14,128 | 12,019 | 4,425 | 3,629 | 2,248 | 1,733 |
Operating Income | -11,123 | -9,662 | -3,526 | -3,344 | -1,881 | -1,910 |
Interest Expense | -98.74 | -59.72 | -976.99 | -1,006 | -59.8 | -148.77 |
Interest & Investment Income | 219.35 | 226.03 | 93.96 | 11.59 | 2.73 | 2.08 |
Currency Exchange Gain (Loss) | 2.28 | 8.39 | 6.56 | -3.18 | 2.16 | -3.45 |
Other Non Operating Income (Expenses) | -89.22 | 3.23 | -3,903 | -88.79 | 68.87 | -5.94 |
EBT Excluding Unusual Items | -11,089 | -9,484 | -8,305 | -4,430 | -1,867 | -2,066 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.42 |
Pretax Income | -11,132 | -9,484 | -8,305 | -4,430 | -1,867 | -2,065 |
Net Income | -11,132 | -9,484 | -8,305 | -4,430 | -1,867 | -2,065 |
Net Income to Common | -11,132 | -9,484 | -8,305 | -4,430 | -1,867 | -2,065 |
Shares Outstanding (Basic) | 9 | 8 | 5 | 5 | 0 | 0 |
Shares Outstanding (Diluted) | 9 | 8 | 5 | 5 | 0 | 0 |
Shares Change (YoY) | 14.61% | 47.92% | 9.28% | 4900.41% | -0.00% | - |
EPS (Basic) | -1277.62 | -1177.33 | -1525.00 | -889.00 | -18734.16 | -20723.09 |
EPS (Diluted) | -1277.62 | -1177.33 | -1525.00 | -889.00 | -18734.16 | -20723.09 |
Free Cash Flow | -14,161 | -13,860 | -3,905 | -3,695 | -2,001 | -3,838 |
Free Cash Flow Per Share | -1625.22 | -1720.62 | -717.13 | -741.49 | -20075.22 | -38510.14 |
Gross Margin | 40.71% | 35.84% | 30.82% | 13.85% | 35.66% | -86.56% |
Operating Margin | -150.72% | -146.90% | -120.82% | -162.66% | -182.85% | -935.45% |
Profit Margin | -150.84% | -144.20% | -284.58% | -215.50% | -181.50% | -1011.70% |
Free Cash Flow Margin | -191.88% | -210.74% | -133.82% | -179.74% | -194.49% | -1880.06% |
EBITDA | -10,542 | -9,197 | -3,230 | -3,109 | -1,726 | -1,818 |
EBITDA Margin | -142.84% | -139.84% | -110.67% | -151.22% | -167.78% | - |
D&A For EBITDA | 581.16 | 464.9 | 296.08 | 235.13 | 155.03 | 91.21 |
EBIT | -11,123 | -9,662 | -3,526 | -3,344 | -1,881 | -1,910 |
EBIT Margin | -150.72% | -146.90% | -120.82% | -162.66% | -182.85% | - |
Advertising Expenses | - | 3,840 | 677.12 | 512.56 | 232.71 | 124.23 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.